Elite Pharmaceuticals, Inc.

Visual Financials
Company Name: Elite Pharmaceuticals, Inc.
Ticker Symbol: ELTP
WWW Address: http://www.elitepharma.com
CEO: Nasrat Hakim
No. of Employees: 26
Common Issue Type: CS
Business Description:Elite Pharmaceuticals, Inc is a specialty pharmaceutical company mainly engaged in the development and manufacture of oral, controlled-release products, using proprietary technology.

 
Industry Information: DRUGS - Drug Manufacturers - Other [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 0.177 Unchanged 0.0 0.175 0.177 0.17699 0.18 0.17 468568
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 162.5 917.9 0.00 -0.01 0.00 0.0 0.0 0.40 - 0.11
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close0.18$
PE Ratio - LTM0.0
Market Capitalisation162.5mil
Latest Shares Outstanding917.9mil
Earnings pS (EPS)-0.01$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee357,095$
Effective Tax Rate0.0%
Float695.7mil
Float as % of Shares Outstanding1.0%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.30%
Research & Devlopment (R&D) as % of Revenue1.00%
Gross Profit Margin64.1%
EBITDA Margin-4.3%
Pre-Tax Profit Margin0.0%
Assets Turnover43.2%
Return on Assets (ROA)-34.5%
Return on Equity (ROE)0.0%
Return on Capital Invested (ROCI)0.0%
Current Ratio3.6
Leverage Ratio (Assets/Equity)
Interest Cover
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS0.01$
Cash pS0.01$
Book-Value pS0.03$
Tangible Book-Value pS-0.04$
Cash Flow pS0.00$
Free Cash Flow pS-0.01$
KEY FIGURES (LTM): Price info
Price/Book Ratio6.24
Price/Tangible Book Ratio0.00
Price/Cash Flow-43.5
Price/Free Cash Flow-30.4
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week----6.8-81,668,9817,455,510
4 Weeks0.250.150.1612.0111,697,30635,643,440
13 Weeks0.250.130.1332.1301,001,20366,079,452
26 Weeks0.250.130.1423.0141,043,280131,453,314
52 Weeks0.400.110.32-43.9-591,328,526334,788,625
YTD0.250.13-18.0111,057,873106,845,179
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
0.190.210.170.160.160.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.240.80.54
Income0.0
Dividend0.0
Capital SpendingNA
R&D-24.03NA5.48
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %6.030.9-43.2
Earnings %0.06.90.0
EPS %0.00.00.0
EPS $0.030.000.08
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio37.83
Current Ratio3.6
Quick Ratio (Acid Test)2.8
Liquidity Ratio (Cash)4.95
Receivables Turnover8.4
Average Collection Period43
Working Capital/Equity0.0
Working Capital pS0.01
Cash-Flow pS0.00
Free Cash-Flow pS-0.01
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio2.20
Financial Leverage Ratio (Assets/Equity)0.0
Debt Ratio9.8
Total Debt/Equity (Gearing Ratio)0.00
LT Debt/Equity0.00
LT Debt/Capital Invested-201.2
LT Debt/Total Liabilities59.0
Interest Cover0.0
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio70.12
Tobin's Q Ratio5.10
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA-380.71
Enterprise Value (EV)/Free Cash Flow-32.23
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM6.24
Price/Cash Flow Ratio-43.5
Price/Free Cash Flow Ratio - LTM-30.4
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio26.2
5-Y Low P/E Ratio1.4
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E-65
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS0.00
Current Liabilities pS0.01
Tangible Book Value pS - LTM-0.04
Book Value pS - LTM0.03
Capital Invested pS-0.03
Cash pS - LTM0.01
Cash Flow pS - LTM0.00
Free Cash Flow pS - LTM-0.01
Earnings pS (EPS)-0.01
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin-37.72
Free Cash Flow Margin 5YEAR AVG-48.93
Net Profit Margin-0.1
Net Profit Margin - 5YEAR AVRG.-4.4
Equity Productivity-0.38
Return on Equity (ROE)0.0
Return on Equity (ROE) - 5YEAR AVRG.
Capital Invested Productivity-0.42
Return on Capital Invested (ROCI)0.0
Return on Capital Invested (ROCI) - 5YEAR AVRG.
Assets Productivity0.40
Return on Assets (ROA)-0.3
Return on Assets (ROA) - 5YEAR AVRG.-1.2
Gross Profit Margin64.1
Gross Profit Margin - 5YEAR AVRG.0.4
EBITDA Margin - LTM-4.3
EBIT Margin - LTM-9.6
Pre-Tax Profit Margin-4.3
Pre-Tax Profit Margin - 5YEAR AVRG.-4.3
Effective Tax Rate-0.3
Effective Tax Rate - 5YEAR AVRG.1.1
EFFICIENCY RATIOS
Cash Conversion Cycle35,207
Revenue per Employee357,095
Net Income per Employee
Average Collection Period35,207
Receivables Turnover8.4
Day's Inventory Turnover Ratio
Inventory Turnover1.4
Inventory/Sales26.4
Accounts Payble/Sales14.44
Assets/Revenue2.50
Net Working Capital Turnover1.04
Fixed Assets Turnover0.82
Total Assets Turnover0.4
Revenue per $ Cash1.09
Revenue per $ Plant1.54
Revenue per $ Common Equity0.00
Revenue per $ Capital Invested0.00
Selling, General & Adm/tive (SG&A) as % of Revenue25.9
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue99.4
R&D Expense as % of Revenue - 5YEAR AVRG.99.4

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.